UNH Breakout: Next Target $400?

UnitedHealth continues to jump after the health insurer reaffirmed its full-year 2025 earnings outlook. The company said it continues to expect adjusted earnings of at least $16.00 per share with revenue in the range of $445.5 billion to $448.0 billion. Wall Street currently forecasts earnings of $16.24 per share on revenue near $448.2 billion. ----------- After breaking the key resistance level of $320, is UNH hitting the short term peak? Have you jumped on the wagon with Buffett?

avatarWeChats
2025-09-16
📈 UNH Breakout: Buffett’s Healthcare Bet — $400 Next? UnitedHealth ($UnitedHealth(UNH)$  $UnitedHealth(UNH)$  ) just smashed through its $320 resistance, and the momentum is catching fire. After reaffirming its 2025 earnings outlook — with EPS projected at $16.00+ and revenue guided at $445.5B–$448B — Wall Street is getting even bolder. Consensus estimates sit slightly higher, with $16.24 EPS on ~$448.2B revenue. The stock’s rally has reignited the debate: is UNH a defensive giant quietly transforming into a growth story, or is this the moment to lock in profits before the climb stalls? Add in the fact that Warren Buffett loaded up $1.6B at an average $314 — and the story gets even juici
22
avatarBarcode
2025-09-10

🚑📊🔥 $UNH: The Mother of All Short Covers? Thank You, Mr. Buffett! 🚑📊🔥

$UnitedHealth(UNH)$ $Alibaba(BABA)$ $SPDR S&P 500 ETF Trust(SPY)$ I’m fully convinced $UNH is setting up for one of the most asymmetric upside trades of the year. With Berkshire’s stake anchoring conviction, Congressional buys lighting the fuse, shorts overloaded, and fundamentals stabilizing, this looks less like a recovery and more like a full-scale rerating. 🧮 Discounted Cashflow Conviction I’ve run the DCF, and the result is decisive. Equity value per share comes in at $580.03, nearly 70% upside from here. Present value of the next decade of cashflows plus terminal value makes the current market price deeply disconnected from intrinsic worth. At an 8.5% dis
3520
🚑📊🔥 $UNH: The Mother of All Short Covers? Thank You, Mr. Buffett! 🚑📊🔥
avatarTigerClub
2025-09-10

🎁What the Tigers Say | UNH Breakout: Have You Profited From Buffet's Pick?

UnitedHealth continues to jump after the health insurer reaffirmed its full-year 2025 earnings outlook.The company said it continues to expect adjusted earnings of at least $16.00 per share with revenue in the range of $445.5 billion to $448.0 billion. Wall Street currently forecasts earnings of $16.24 per share on revenue near $448.2 billion.After breaking the key resistance level of $320, is UNH hitting the short term peak?Have you jumped on the wagon with Buffett?🎁Special Notes: Whoever showed up on the” What the Tigers Say” column will receive 100 Tiger Coins and an exclusive interview invitation to honor your contribution.Click titles to read the full analysis:1. @TwoDeMoon:Key Points:This is a defensive and fundamental / value pi
2414
🎁What the Tigers Say | UNH Breakout: Have You Profited From Buffet's Pick?
avatarWeChats
2025-09-10
$UnitedHealth(UNH)$ $UnitedHealth(UNH)$   📈 UNH Breakout: Buffett’s Healthcare Bet Roars Past $320 — Buy or Bail? UnitedHealth Group (UNH) has smashed through the $320 resistance level, sending a clear signal to Wall Street: healthcare’s quiet giant isn’t done yet. With a reaffirmed 2025 outlook of $16+ EPS and revenue guidance of $445B–$448B, the numbers are steady. Wall Street’s consensus is even bolder, penciling in $16.24 EPS on ~$448.2B revenue. But here’s what’s really fueling excitement: Warren Buffett’s $1.6B stake. When the Oracle of Omaha places a billion-dollar bet, retail investors notice. UNH suddenly looks less like a slow-moving insurer and more like a
126
avatarXaddy_Analyst
2025-09-10

UNH Surge: Buffett's Pick or Tariff Trap?

$UnitedHealth(UNH)$ UnitedHealth Group (UNH) shares surged after reaffirming its 2025 earnings outlook of at least $16 per share on revenue of $445.5-$448 billion, slightly below Wall Street's $16.24 EPS and $448.2 billion forecast, but signaling confidence amid healthcare challenges. The stock, a Buffett favorite through Berkshire Hathaway's 1.1 million share stake, trades at $320.25, up 8.76% recently, with analysts maintaining a Buy rating and $387.63 average target. With the S&P 500 at 6,520, Nasdaq at 21,950, and Bitcoin at $123,456, the VIX at 14.12 reflects calm amid oil at $74.50/barrel. Posts found on X buzz with "UNH rebound" optimism, but tariff fears linger. This deep dive explores the reaffirmation, current stance, future prospects
3Reply
UNH Surge: Buffett's Pick or Tariff Trap?
avatarorsiri
2025-09-13

Healthy Profits or Price Headache? UNH’s Road to $400

UnitedHealth Group is a stock in need of a second opinion. Trading at $353, down more than 40 per cent from its 52-week high, it sits at a valuation multiple of just 15 times earnings — modest for a company that still pulls in over $420 billion in annual revenue. The market is clearly pricing in lasting damage. I think the case is more nuanced. If Optum can recover margins, if Medicare Advantage scrutiny is contained, and if capital returns are deployed with conviction, then the climb back to $400 is achievable. Networks align: Optum’s reach could redraw healthcare’s balance sheet Optum’s margin pulse Optum has become the engine that keeps $UnitedHealth(UNH)$ competitive. It now accounts for nearly half of operating earnings, yet recent quarters ha
112
Healthy Profits or Price Headache? UNH’s Road to $400
avatarBarcode
2025-09-09

🚑📈💊 UnitedHealth Ignites a Healthcare Wedge Breakout 🚑📈💊

$UnitedHealth(UNH)$ $Direxion Daily Healthcare Bull 3X Shares(CURE)$ I’m fully convinced this move in UnitedHealth ($UNH) isn’t just noise; it’s the ignition point that could reshape healthcare momentum across both single-stock and leveraged ETF structures. 💡 UnitedHealth Inverse Head & Shoulders (Micro Frame) This morning’s price action confirmed the bullish IHS breakout with $318 now acting as the inflection pivot. As long as that level holds, the setup points toward $325–$330. Options flow backs it up: calls are leading with a 0.28 put/call ratio, IV30 elevated to 34.33, and expected daily swings near $6.90. The skew flattening signals traders aren’t hedging downside, they’re leaning into upside con
41730
🚑📈💊 UnitedHealth Ignites a Healthcare Wedge Breakout 🚑📈💊
avatarXaddy_Analyst
2025-08-20

Wall Street’s UNH Rush: Can It Hit $200 and Beyond This W

$UnitedHealth(UNH)$ Wall Street’s biggest names are betting big on UnitedHealth Group (UNH), with Warren Buffett’s Berkshire Hathaway leading the charge alongside Renaissance Technologies, David Tepper’s Appaloosa Management, and Michael Burry’s Scion Asset Management. As of August 19, 2025, UNH closed at $308.49, a stunning 11.98% jump in 24 hours, fueled by these heavyweight investments. With the S&P 500 at 6,466.58, Bitcoin at $124,002, and oil at $75/barrel amid 30-35% tariffs, the rally stands out, though the VIX at 14.49 suggests calm waters—or a brewing storm. Trading at a P/E of 12, near a decade-low valuation, UNH’s plunge from $630.73 to $234.60 over the past year has sparked a buying frenzy. Can it close above $200 this week, or is t
52
Wall Street’s UNH Rush: Can It Hit $200 and Beyond This W
avatarSpiders
2025-08-21

Wall Street Piles Into UNH: Will it Close at ___ This Week?

It’s not just Warren Buffett—top global quant fund Renaissance Technologies, David Tepper’s Appaloosa Management, and legendary investor Michael Burry have all taken positions in UnitedHealth Group (UNH). This convergence of heavyweights signals strong institutional confidence, even as short-term regulatory and cost pressures linger. With the stock’s valuation currently at historic lows, investors are starting to wonder: could this be the perfect entry point? UnitedHealth (UNH) A Closer Look at UnitedHealth Group UnitedHealth Group isn’t your average health insurer—it’s a sprawling, diversified healthcare empire. The company operates through four core segments: UnitedHealthcare – Provides health benefit plans and services to individuals, small and large businesses, public sector employers,
Repost1
Wall Street Piles Into UNH: Will it Close at ___ This Week?
avatarLanceljx
2025-08-19
$UnitedHealth(UNH)$   Is Buying UNH the "Easiest Trade" This Year? Attractiveness: The recent rally in UNH stock stems from high-profile value investors—including Warren Buffett (via Berkshire Hathaway), Appaloosa Management, and Michael Burry—taking positions in what they perceive as an oversold, high-quality company . Valuation: The stock now trades at a forward P/E of approximately 15–16 times—significantly below both its own five-year average (~19) and the S&P 500 average—making UNH relatively inexpensive by historical and market standards . Additionally, its generous dividend yield (~3%) reinforces its appeal to income-focused investors . Wall Street Sentiment: Analyst consensus remains broadly favorable
RepostReply
avatarTiger_comments
2025-08-19

[Game] UNH is the easiest trade of 2025? Where will it close this Friday?

It’s not just Buffett—top global quant fund Renaissance Technologies, David Tepper’s Appaloosa Management, and legendary investor Michael Burry have also piled in. While short-term regulatory and cost risks can’t be ignored, the company’s valuation has fallen to historic lows.64c2aa1f57024896b2fd019d2800c5d0.pngHow much upside is left for Buffett’s pick? $Taiwan Semiconductor Manufacturing(TSM)$ , which Buffett sold early, has surged 251.47% over the past three years.In Q3 2022, Berkshire Hathaway made a large bet on TSMC, making it its 10th largest holding. However, just one quarter later, Buffett sold 86% of his TSMC shares and fully exited in Q1 2023.Buffett bought TSMC around $68.2 per share in Q3 2022, at a P/E of roughly 11.3×, historically l
3642
[Game] UNH is the easiest trade of 2025? Where will it close this Friday?
avatarBarcode
2025-08-15

💎 🏥 🚀 Berkshire, Burry & Tepper Unleash Billion-Dollar UNH Bet: The Market’s Next $600 Giant? 🚀 🏥 💎

$UnitedHealth(UNH)$ $Regeneron Pharmaceuticals(REGN)$ $Meta Platforms, Inc.(META)$💎 I’m calling this the most coordinated institutional strike on a Dow component this year, with Buffett, Burry, and Tepper all betting on a V-shaped recovery from multi-year lows. Institutional Endorsement Sparks Double-Digit After-Hours Surge I’m leaning into UnitedHealth here because the tape just flipped from distress to endorsement; Berkshire Hathaway disclosed a new 5.04 million-share stake worth about $1.57 billion and UNH ripped roughly 12 percent after-hours to $300.50 on 14Aug25 (SEC, MarketWatch, 14Aug25). Scion Asset Management revealed $190 million in UNH call options plu
5331
💎 🏥 🚀 Berkshire, Burry & Tepper Unleash Billion-Dollar UNH Bet: The Market’s Next $600 Giant? 🚀 🏥 💎
avatarShyon
2025-08-19
I find it intriguing that Wall Street is piling into $UnitedHealth(UNH)$  , with the question of whether UNH will close above 320 this week sparking a lot of interest. The involvement of major players like Buffett, Renaissance Technologies, David Tepper's Appaloosa Management, and legendary investor Michael Burry certainly adds weight to the conversation. It is fascinating to see such prominent figures taking notice. I note that while short-term regulatory and cost risks cannot be ignored, the company's valuation has fallen to historic lows. This drop could present a unique opportunity, and I am curious about how these factors will play out in the coming days. The market's perception of value seems to be shifting
RepostReply
avatarWeChats
2025-08-15
$UnitedHealth(UNH)$   Buffett Drops $1.6B on UnitedHealth — Are You Buying at $300? 🚀📊 When Warren Buffett moves, markets pay attention. In Berkshire Hathaway’s latest Q2 2025 13F, the Oracle of Omaha revealed a $1.6 billion stake in UnitedHealth Group (UNH) — buying in at an average of $314 per share. Today, UNH trades below Buffett’s cost at ~$300. 👉 The rare question for retail investors: Do you buy with Buffett… or wait for a deeper pullback? --- Why UNH Could Be Buffett’s Quiet Power Play 💡 Buffett has dipped into healthcare before — but this is the #1 US health insurer, serving 50M+ members and dominating Medicare Advantage. Why now? 📉 Valuation reset: Down from $550 in 2022 to ~$300 after policy fears 🛡 De
437
avatarBabySim
2025-09-14
$UnitedHealth(UNH)$   Support for a move toward $400: 1. Strong fundamentals: UnitedHealth has diversified business (healthcare plans + services, via Optum etc.), strong cash flow, and decent earnings growth. Those help build a base for higher valuations.  2. Recent upgrades and raised targets: Some upgrades (like at Truist) show increasing confidence. These tend to help with investor sentiment.  3. Room for multiple expansion: If UNH can demonstrate margin improvement, reduce regulatory risk, or show accelerating growth, the market may reward it with a higher P/E, pushing the price up. Challenges / what needs to go right / risk factors: • Regulatory risk is nontrivial for big health insurers. Changes in Medicare/Medicaid policy, reimbu
14
avatarBarcode
2025-09-14
$UnitedHealth(UNH)$ 💊📈🛡️ $UNH Breakout With Value Compounding 💊📈🛡️ I see UnitedHealth breaking out as a value compounder hiding in plain sight. Despite people served falling (–4.08% YoY), Optum Health growth offsets declines, driving superior cash returns. At just 15.2x P/E and a 7.92% FCF yield, the setup is compelling. Breakout over $350 now sets short-term target $370 and medium-term path toward $395–400. Support holds at $345–347, and history shows UNH breakouts of this structure deliver 12–15% measured moves. Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
42524
avatarBarcode
2025-08-16

💉🏥🚀 Buffett’s $1.6B Shockwave in UNH Sparks a Managed Care Breakout: CNC & MOH Poised to Rip 🚀🏥💉

$UnitedHealth(UNH)$ $Centene(CNC)$ $Molina Healthcare(MOH)$ I’m tracking one of the most asymmetric setups in years as Buffett’s $1.6B UNH buy ignites CNC and MOH, Medicaid policy shifts add fuel, and hedge fund flows collide with a $1.2M bearish bet, setting the stage for a sector-wide repricing that could move fast. From Deep Value to Breakout: Medicaid Giant Reclaims Momentum I’m seeing CNC surge 6.02% to $28.55, breaking above its 20-day MA with volume support after weeks of accumulation. Medicaid exposure is the highest in the sector at 45.8% of its total medical book, with 12.8m lives covered. A 100 bps margin compression in Medicaid would hit EPS by 66.2%, ye
205
💉🏥🚀 Buffett’s $1.6B Shockwave in UNH Sparks a Managed Care Breakout: CNC & MOH Poised to Rip 🚀🏥💉
avatarWallStreet_Tiger
2025-08-15

Buffett added UnitedHealth, Nucor, Lennar and Lamar in Q2, Copy Trades?

1. The Trend in Berkshire Hathaway's 13F Filing: Cashing in on Technology at a High Level, and Shifting to a Left-Side Position in Industrials, Real Estate, and UtilitiesAfter the market closed on August 14, 2025, $Berkshire Hathaway(BRK.B)$ $Berkshire Hathaway(BRK.A)$ filed its 13F report, which shows:Divestments: $Apple(AAPL)$ by 20 million shares (-6.7%), $Bank of America(BAC)$ by 26.3 million shares (-4.2%);Liquidations: $T-Mobile US(TMUS)$New Entries/Increases: $UnitedHealth(UNH)$ by 5.04 million shares, a small increase in
191
Buffett added UnitedHealth, Nucor, Lennar and Lamar in Q2, Copy Trades?
avatarTigerPicks
2025-07-30

Holding any oversold quality names? 📊 Dive into TigerAI’s 15 battered Dow megacaps.

$UnitedHealth(UNH)$ led the decline of 15 high-quality $Dow Jones(.DJI)$ components with a market capitalization over $100 billion.Do you own any oversold high-quality stocks?📈 Check out TigerAI's analysis.I. $UnitedHealth(UNH)$ declined almost 8 % on Tuesday after releasing earnings.Key facts of $UnitedHealth(UNH)$• Reported 29-Jul-2025 pre-market; stock closed –7.9 %.• Options volume ranked #5 across all US names that day.• YTD 2025 (to 29 Jul) UNH is –48.39 %, the steepest drop among US mega-caps (≥ 100 bn USD).• Tiger Trade “Top Bought” leaderboard: UNH has been the #2 most-bought stock over the last 20-, 10-, 5-, 3- an
162
Holding any oversold quality names? 📊 Dive into TigerAI’s 15 battered Dow megacaps.
avatarXaddy_Analyst
2025-07-29

UnitedHealth’s $250 Dip: A Golden Opportunity or a Risky Bet?

UnitedHealth Group ( $UnitedHealth(UNH)$ ) faced a rough start to the week, tumbling 5% in premarket trading after its Q2 2025 earnings report on July 29, 2025, missed earnings per share (EPS) expectations and offered a disappointing profit outlook. The health insurance giant reported a Q2 EPS of $4.08, falling short of the consensus forecast of $4.45, while revenue of $111.62 billion slightly exceeded the $111.59 billion expected. With the stock now hovering around $266.10 after the drop, investors are eyeing a potential dip to $250—a level not seen since earlier this year. Is this a golden opportunity to buy a healthcare leader at a discount, or a risky bet amid ongoing challenges? This report dives into UNH’s earnings, the reasons behind the mis
4Reply
UnitedHealth’s $250 Dip: A Golden Opportunity or a Risky Bet?